0001946593-24-000001.txt : 20241226 0001946593-24-000001.hdr.sgml : 20241226 20241226162825 ACCESSION NUMBER: 0001946593-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241226 DATE AS OF CHANGE: 20241226 EFFECTIVENESS DATE: 20241226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnPlusOne Biosciences Inc. CENTRAL INDEX KEY: 0001946593 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-460553 FILM NUMBER: 241581356 BUSINESS ADDRESS: STREET 1: 313 PLEASANT STREET STREET 2: 4W CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 6177446739 MAIL ADDRESS: STREET 1: 313 PLEASANT STREET STREET 2: 4W CITY: WATERTOWN STATE: MA ZIP: 02472 D/A 1 primary_doc.xml X0708 D/A LIVE 0001946593 EnPlusOne Biosciences Inc. 313 PLEASANT STREET 4W WATERTOWN MA MASSACHUSETTS 02472 6177446739 DELAWARE None None Corporation true 2022 Daniel Wiegand 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Executive Officer Director Daniel Ahlstedt 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Executive Officer Director Daniel Janse 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Andrew Lee 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Steven Kasok 313 Pleasant Street 4W Watertown MA MASSACHUSETTS 02472 Director Biotechnology Decline to Disclose 06b true 0001946593-22-000001 2023-04-10 false true false 0 12896707 12896707 0 The total offering amount and the total amount sold include the conversion of $1,296,705 of outstanding convertible securities. false 6 0 0 0 false EnPlusOne Biosciences Inc. /s/ Daniel Ahlstedt Daniel Ahlstedt Chief OperatingOfficer 2024-12-26